Literature DB >> 8679155

DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.

J Cappiello1, P Nicolai, A R Antonelli, F Facchetti, M Cadei, A Cornacchiari, P G Grigolato.   

Abstract

The DNA index, expression of cell-cycle-related proteins--proliferating cell nuclear antigen (PCNA, cyclin) and Ki-67--and the content of silver-binding nucleolar organizer regions (AgNORs) were evaluated in 30 unselected consecutive primary squamous cell carcinomas of the larynx. Results were compared and subsequently related to histological grading, lymph node status, pT category, and pathological stage. DNA content was non-diploid in 9 cases (30%). Mean AgNOR counts per tumor ranged from 2.52 to 8.76. PCNA and Ki-67 expressions were similar in 10 cases (33%). In the remaining cases, PCNA-positive cells usually outnumbered Ki-67-positive cells. No significant correlation was found among DNA index, PCNA and Ki-67 expressions, and AgNOR counts. Although there was a positive trend when Ki-67 was compared with histological grading, findings were not statistically significant. In contrast, a significant correlation was found between DNA index and lymph node status (P = 0.035), with a higher incidence of neck node metastases in non-diploid tumors. These data suggest that tumor ploidy can be correlated with lymph node spread in laryngeal squamous cell carcinoma and might be used as an additional prognostic factor when planning treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8679155     DOI: 10.1007/bf00178276

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region.

Authors:  W A Kokal; R L Gardine; K Sheibani; I W Zak; J D Beatty; D U Riihimaki; L D Wagman; J J Terz
Journal:  Am J Surg       Date:  1988-10       Impact factor: 2.565

2.  Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores.

Authors:  P A Dervan; L G Gilmartin; B M Loftus; D N Carney
Journal:  Am J Clin Pathol       Date:  1989-10       Impact factor: 2.493

Review 3.  Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer.

Authors:  C M Fenoglio-Preiser
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

4.  Nucleolar organizer regions (NORs) and myoepitheliomas: a comparison with DNA content and clinical course.

Authors:  R Carrillo; A K el-Naggar; M A Luna; J L Rodriguez-Peralto; J G Batsakis
Journal:  J Laryngol Otol       Date:  1992-07       Impact factor: 1.469

5.  Prognostic implications of nuclear DNA content in head and neck cancer.

Authors:  Y C Guo; L DeSanto; G V Osetinsky
Journal:  Otolaryngol Head Neck Surg       Date:  1989-02       Impact factor: 3.497

6.  Diagnosis and grading of malignancy in squamous epithelial lesions of the larynx with DNA cytophotometry.

Authors:  A Böcking; W Auffermann; H Vogel; G Schlöndorff; R Goebbels
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

7.  Flow cytometric evaluation of cell dispersion from human head and neck tumors.

Authors:  J T Bijman; D J Wagener; H van Rennes; J M Wessels; P van den Broek
Journal:  Cytometry       Date:  1985-07

8.  Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.

Authors:  G Fontanini; R Pingitore; D Bigini; S Vignati; S Pepe; A Ruggiero; P Macchiarini
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

9.  Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis.

Authors:  L E Holm
Journal:  Laryngoscope       Date:  1982-09       Impact factor: 3.325

10.  Analysis of DNA content in supraglottic epidermoid carcinoma.

Authors:  R Barona de Guzman; M A Martorell; J Basterra; M Armengot; A Montoro; J Montoro
Journal:  Otolaryngol Head Neck Surg       Date:  1993-06       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.